In fairness, Remdesivir and HCQ as antivirals maybe more in competition with each other in milder cases of CV than Leronlimab I would like to see US data on Dr. Raoult's regimen (HCQ/ZPak) to see the comparison with Remdesivir when they are both released. They both should be available soon I imagine. Also maybe combining with Vit C, D, and Zinc to boost potential antiviral effect.

Remdesivir is IV infusion daily which mandates travel to hospital, or clinic daily. Leronlimab and HCQ can be self administered at home. The side effect profile of Remdesivir appears to be worse than HCQ. Just IMO